Mineralys Therapeutics In... (MLYS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
9.69
0.57 (6.25%)
At close: Jan 15, 2025, 12:30 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 |
PE Ratio | -4.33 | -25.28 | -37.11 | -210.22 |
PS Ratio | n/a | n/a | n/a | n/a |
PB Ratio | 1.29 | -14.41 | -31.42 | -200.22 |
P/FCF Ratio | -3.83 | -25.78 | -49.47 | -292.41 |
P/OCF Ratio | -3.83 | -25.78 | -49.47 | -292.41 |
OCF/S Ratio | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | -1.25 |
Quick Ratio | 23.76 | 13.65 | 2.20 | 0.29 |
Current Ratio | 23.76 | 13.65 | 2.20 | 0.29 |
Asset Turnover | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -18.78 | -693.52 | -25.59 |
Return on Equity (ROE) | -0.3 | 0.57 | 0.85 | 0.95 |
Return on Assets (ROA) | -0.29 | -0.26 | -1.74 | -2.31 |
Return on Capital (ROIC) | -0.35 | -0.3 | -3.08 | 0.82 |
Dividend Yield | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a |